Mutual cross-modulation of steroid/retinoic acid receptor and AP-1 transcription factor activities: a novel property...

Area of Science:

• Molecular Biology
• Cellular Biology
• Genetics

Background:

• Nuclear receptors and AP-1 transcription factors (Jun/Fos/ATF families) exhibit complex mutual regulatory interactions.
• This cross-modulation can be positive or negative, with negative interference being particularly relevant for therapeutic applications.
• Previous research on this interaction has yielded diverse and sometimes conflicting findings.

Purpose of the Study:

• To elucidate the mechanisms underlying the cross-modulation between nuclear receptors and AP-1 transcription factors.
• To reconcile conflicting experimental observations regarding this transcription factor interaction.
• To identify therapeutic strategies based on modulating these interactions.

Main Methods:

• Analysis of experimental evidence to develop a unifying model for nuclear receptor-AP-1 interaction.
• Investigating the separable activities of nuclear receptors, specifically transactivation and transrepression.
• Utilizing point mutations in the glucocorticoid receptor and ligand analogues to probe functional mechanisms.

Main Results:

• Nuclear receptor monomers, not dimers, appear to mediate the cross-modulatory effects.
• Transactivation and transrepression functions of nuclear receptors are separable.
• Ligand analogues selectively inhibit transactivation, suggesting distinct mechanisms for modulation and activation.

Conclusions:

• A refined model for nuclear receptor and AP-1 transcription factor cross-modulation is proposed.
• Nuclear receptor monomers are key players in modulating AP-1 activity.
• Targeting ligands that enhance cross-modulation without inducing transactivation presents a promising therapeutic avenue.